Literature DB >> 11282239

Drug delivery by phospholipase A(2) degradable liposomes.

J Davidsen1, C Vermehren, S Frokjaer, O G Mouritsen, K Jørgensen.   

Abstract

The effect of poly(ethylene glycol)-phospholipid (PE-PEG) lipopolymers on phospholipase A(2) (PLA(2)) hydrolysis of liposomes composed of stearoyl-oleoylphosphatidylcholine (SOPC) was investigated. The PLA(2) lag-time, which is inversely related to the enzymatic activity, was determined by fluorescence, and the zeta-potentials of the liposomes were measured as a function of PE-PEG lipopolymer concentration. A significant decrease in the lag-time, and hence an increase in enzymatic activity, was observed with increasing amounts of the negatively charged PE-PEG lipopolymers incorporated into the SOPC liposomes. The enhancement of the PLA(2) enzymatic activity might involve a stronger PLA(2) binding affinity towards the negatively charged and polymer covered PEG liposomes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11282239     DOI: 10.1016/s0378-5173(00)00634-7

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  13 in total

1.  Synthesis of lipids for development of multifunctional lipid-based drug-carriers.

Authors:  Guodong Zhu; Yahya Alhamhoom; Brian S Cummings; Robert D Arnold
Journal:  Bioorg Med Chem Lett       Date:  2011-09-08       Impact factor: 2.823

Review 2.  Experimental and theoretical investigations in stimuli responsive dendrimer-based assemblies.

Authors:  Mijanur Rahaman Molla; Poornima Rangadurai; Giovanni M Pavan; S Thayumanavan
Journal:  Nanoscale       Date:  2015-03-07       Impact factor: 7.790

3.  Peptide-micelle hybrids containing fasudil for targeted delivery to the pulmonary arteries and arterioles to treat pulmonary arterial hypertension.

Authors:  Nilesh Gupta; Hany M Ibrahim; Fakhrul Ahsan
Journal:  J Pharm Sci       Date:  2014-09-29       Impact factor: 3.534

Review 4.  Enzyme-Responsive Liposomes for the Delivery of Anticancer Drugs.

Authors:  Farnaz Fouladi; Kristine J Steffen; Sanku Mallik
Journal:  Bioconjug Chem       Date:  2017-03-08       Impact factor: 4.774

5.  Human NAD(P)H:quinone oxidoreductase type I (hNQO1) activation of quinone propionic acid trigger groups.

Authors:  Maria F Mendoza; Nicole M Hollabaugh; Suraj U Hettiarachchi; Robin L McCarley
Journal:  Biochemistry       Date:  2012-09-28       Impact factor: 3.162

6.  Light-Induced Content Release from Plasmon Resonant Liposomes.

Authors:  Timothy S Troutman; Sarah J Leung; Marek Romanowski
Journal:  Adv Mater       Date:  2009-06-12       Impact factor: 30.849

7.  Stimuli Sensitive Amphiphilic Dendrimers.

Authors:  R Rajasekhar Reddy; Krishna R Raghupathi; Diego Amado Torres; S Thayumanavan
Journal:  New J Chem       Date:  2012-02-01       Impact factor: 3.591

8.  Solubilization of beclomethasone dipropionate in sterically stabilized phospholipid nanomicelles (SSMs): physicochemical and in vitro evaluations.

Authors:  Mohanad Naji Sahib; Shaymaa Abdalwahed Abdulameer; Yusrida Darwis; Kok Khiang Peh; Yvonne Tze Fung Tan
Journal:  Drug Des Devel Ther       Date:  2012       Impact factor: 4.162

9.  Gelatinase-stimuli strategy enhances the tumor delivery and therapeutic efficacy of docetaxel-loaded poly(ethylene glycol)-poly(ɛ-caprolactone) nanoparticles.

Authors:  Qin Liu; Ru-Tian Li; Han-Qing Qian; Mi Yang; Zhen-Shu Zhu; Wei Wu; Xiao-Ping Qian; Li-Xia Yu; Xi-Qun Jiang; Bao-Rui Liu
Journal:  Int J Nanomedicine       Date:  2012-01-20

Review 10.  Nanocarriers as pulmonary drug delivery systems to treat and to diagnose respiratory and non respiratory diseases.

Authors:  Malgorzata Smola; Thierry Vandamme; Adam Sokolowski
Journal:  Int J Nanomedicine       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.